Position in MEDP
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,816,550
+$3,790,715 QoQ
Shares Held
7,948
+17178.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NATIXIS holds $131,242,925 across 14 Diagnostics & Research names. MEDP ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
212,832 | $40,352,947 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
66,593 | $32,732,457 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
12,592 | $15,881,030 | |
| 4 | GRAL |
GRAIL, Inc.
|
199,368 | $10,303,338 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
18,018 | $10,124,134 | |
| 6 | DGX |
Quest Diagnostics Inc
|
28,191 | $5,524,872 | |
| 7 | WAT |
Waters Corp /De/
|
16,488 | $4,910,126 | |
| 8 | MEDP |
Medpace Holdings, Inc.
This page
|
7,948 | $3,816,550 |
All Filings in MEDP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,816,550 | 7,948 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,835 | 46 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $53,983 | 172 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,508 | 87 | Shares | Sole | 2025-07-18 | |
| 2024-06-30 | $3,706 | 9 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $727,470 | 1,800 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||